Stockreport

Atai Life Sciences N.V. (ATAI) Secures Patent for Social Anxiety Disorder Formulation [Yahoo! Finance]

Atai Beckley N.V - Common Shares  (ATAI) 
US:NASDAQ Investor Relations: ir.atai.net.cn
PDF from 8 analysts, with a 12-month average target of $12.71 (range $10–$16), implying a 204% upside from the current $4.18. Pressmaster/Shutterstock.com On December 11 [Read more]